Multivariate adaptive regression spline modeling for estimating carotid artery plaque thickness in Chinese men with type 2 diabetes

J Int Med Res. 2026 Aug;54(8):3000605261476583. doi: 10.1177/03000605261476583. Epub 2026 Aug 28.ABSTRACTObjectiveThe incidence of type 2 diabetes continues to increase worldwide, with cardiovascular disease as the leading cause of mortality in this population. Carotid artery plaque thickness serves

C Chung-Chi Yang

Clinical analyses of angiotensin-converting enzyme inhibitor users presenting with cough to a chest diseases outpatient clinic: A single-center retrospective study

J Int Med Res. 2026 Aug;54(8):3000605261481609. doi: 10.1177/03000605261481609. Epub 2026 Aug 28.ABSTRACTObjectiveAngiotensin-converting enzyme inhibitors are widely prescribed for cardiovascular disease and are a well-recognized cause of cough. However, cough in patients treated with angiotensin-co

H Hayriye Bektaş Aksoy

Machine Learning-Driven Risk Prediction Model in Transthyretin Amyloid Cardiomyopathy

JAMA Cardiol. 2026 Aug 28. doi: 10.1001/jamacardio.2026.3496. Online ahead of print.ABSTRACTIMPORTANCE: Transthyretin cardiac amyloidosis (ATTR-CM) is associated with poor prognosis and significant morbidity and mortality, yet existing staging systems have limited ability to accurately predict outco

G Giovanni Baj

The association between carbon monoxide and cardiovascular-kidney-metabolic syndrome in the Chinese populations: China Health and Retirement Longitudinal Study

J Nephrol. 2026 Aug 28:aajag173. doi: 10.1093/joneph/aajag173. Online ahead of print.ABSTRACTBACKGROUND: Cardiovascular-kidney-metabolic (CKM) syndrome is characterized by both high prevalence and mortality rates. Air pollution, a recognized risk factor for cardiovascular disease and a key component

X Xuemin Yin

Genetic Risk of Cardiovascular Disease Among People With No Standard Modifiable Risk Factors

No abstractJACC Adv. 2026 Aug 28:103203. doi: 10.1016/j.jacadv.2026.103203. Online ahead of print.NO ABSTRACTPMID:42663373 | DOI:10.1016/j.jacadv.2026.103203

R Raysha Farah

Sex-Specific Differences in Patient-Centered Outcomes After Transcatheter Aortic Valve Replacement

JACC Adv. 2026 Aug 13:103175. doi: 10.1016/j.jacadv.2026.103175. Online ahead of print.ABSTRACTBACKGROUND: Sex-specific disparities in patient-reported outcomes among patients undergoing transcatheter aortic valve replacement (TAVR) are not fully investigated.OBJECTIVES: The objective of the study w

D Daijiro Tomii

Determinants and Clinical Interpretation of Circulating Transthyretin in ATTR Amyloidosis

JACC Adv. 2026 Jul 23:103047. doi: 10.1016/j.jacadv.2026.103047. Online ahead of print.ABSTRACTBACKGROUND: Transthyretin (TTR) amyloidosis (ATTR) ranges from localized to systemic disease, but the clinical interpretation of circulating TTR remains uncertain.OBJECTIVES: The objective of the study was

T Toshihiro Tsuruda

Incremental Predictive Value of Deep Learning-Quantified Coronary Atherosclerotic Volume: A SCAPIS Cohort Analysis

JACC Cardiovasc Imaging. 2026 Aug 21:S1936-878X(26)00438-9. doi: 10.1016/j.jcmg.2026.08.004. Online ahead of print.ABSTRACTBACKGROUND: Coronary plaque volume assessed by coronary computed tomography angiography (CTA) may refine risk assessment beyond established risk models.OBJECTIVES: This study ai

J Johan Malmqvist

Cumulative Benefit With Evolocumab in Patients With No Prior Myocardial Infarction or Stroke in the VESALIUS-CV Study

J Am Coll Cardiol. 2026 Aug 28:S0735-1097(26)07440-1. doi: 10.1016/j.jacc.2026.08.015. Online ahead of print.ABSTRACTBACKGROUND: Proprotein convertase subtilisin/kexin type 9 inhibition with evolocumab reduced the risk of a first major adverse cardiovascular event (MACE) in patients at high cardiova

J Jose C Nicolau

Low-Normal Hemoglobin Concentrations and Clinical Outcomes in Heart Failure

J Am Coll Cardiol. 2026 Aug 28:S0735-1097(26)07437-1. doi: 10.1016/j.jacc.2026.08.013. Online ahead of print.ABSTRACTBACKGROUND: The World Health Organization (WHO) defines anemia as hemoglobin concentration <12 g/dL in women and <13 g/dL in men. Although widely used clinically, these thresholds wer

M Misato Chimura

Bivalirudin Versus Heparin in Low and Non-Low Bleeding Risk Patients Undergoing Primary PCI for STEMI: The BRIGHT-4 Trial

J Am Coll Cardiol. 2026 Jul 27:S0735-1097(26)06997-4. doi: 10.1016/j.jacc.2026.06.035. Online ahead of print.ABSTRACTBACKGROUND: In the BRIGHT-4 trial, among 6,016 patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI) with a radi

M Miaohan Qiu

Low-Density Lipoprotein Cholesterol and Venous Thromboembolism: What Rare Variants Teach Us About a Common Disease

No abstractJ Am Coll Cardiol. 2026 Jul 11:S0735-1097(26)06901-9. doi: 10.1016/j.jacc.2026.06.025. Online ahead of print.NO ABSTRACTPMID:42663355 | DOI:10.1016/j.jacc.2026.06.025

S Shoa L Clarke

Genetically Mediated Differences in LDL Cholesterol and Risk of Venous Thromboembolism

J Am Coll Cardiol. 2026 Aug 4:S0735-1097(26)06902-0. doi: 10.1016/j.jacc.2026.06.026. Online ahead of print.ABSTRACTBACKGROUND: Venous thromboembolism (VTE) is a common and clinically significant cardiovascular condition. Although low-density lipoprotein (LDL) cholesterol is causally linked to ather

Y Yang Sui

Left Atrial Mass as the Initial Presentation of Poorly Differentiated Nonsmall Cell Lung Carcinoma

JACC Case Rep. 2026 Aug 27:110007. doi: 10.1016/j.jaccas.2026.110007. Online ahead of print.ABSTRACTBACKGROUND: Lung carcinoma is a leading cause of cancer-related mortality globally. Although metastasis to the bone, brain, and adrenal glands is common, secondary cardiac involvement is exceptionally

M Manjunath Bagur

Coronary Vasospasm in Eosinophilic Granulomatosis With Polyangiitis: A 4-Patient Case Series

JACC Case Rep. 2026 Aug 28:110012. doi: 10.1016/j.jaccas.2026.110012. Online ahead of print.ABSTRACTBACKGROUND: Coronary vasospasm is an uncommon manifestation of eosinophilic granulomatosis with polyangiitis (EGPA), and it may present as recurrent acute coronary syndrome (ACS).CASE SUMMARY: We repo

F Francesco Saverio Rea

SGLT2-Inhibitors and Molecular Signatures of Aortic Valve Remodeling in Severe Aortic Stenosis: The Valve-AS Study

JACC Basic Transl Sci. 2026 Aug 11:101658. doi: 10.1016/j.jacbts.2026.101658. Online ahead of print.ABSTRACTSodium-glucose cotransporter 2 inhibitor (SGLT2i) exerts pleiotropic metabolic and anti-inflammatory effects, but its role in calcific aortic valve stenosis (CAVS) is unclear. In this multicen

P Pasquale Paolisso

Individual Participant Data Meta-Analysis (IPDMA) of long-term COVID-19 outcomes in a systematic review-informed, international, multidisciplinary database

Health Soc Care Deliv Res. 2026 Aug;14(29):1-160. doi: 10.3310/GJMA0602.ABSTRACTBACKGROUND: Identifying and addressing long-term health and societal challenges after COVID-19 is a research priority.OBJECTIVES: To create an international, multidisciplinary COVID-19 database, and synthesise long-term

M Myzoon Ali

Eplontersen for Transthyretin Amyloid Cardiomyopathy

N Engl J Med. 2026 Aug 28. doi: 10.1056/NEJMoa2608510. Online ahead of print.ABSTRACTBACKGROUND: Transthyretin amyloidosis with cardiomyopathy (ATTR-CM) is a progressive, life-threatening disease caused by deposition of misfolded transthyretin (TTR). Eplontersen, an antisense oligonucleotide, reduce

M Marianna Fontana

Research progress on BTG2 in non‑tumor diseases (Review)

Int J Mol Med. 2026 Nov;58(5):299. doi: 10.3892/ijmm.2026.5970. Epub 2026 Aug 28.ABSTRACTThe B‑cell translocation gene 2 (BTG2), originally identified as a tumor suppressor, has been extensively studied in oncology research. However, its multifaceted functions in non‑tumor diseases are still being r

S Shuling Li

Effectiveness of High-Dose versus Standard-Dose Influenza Vaccine against Venous Thromboembolic Events: A Post Hoc Analysis of the DANFLU-2 Trial

No abstractEur J Prev Cardiol. 2026 Aug 28:zwag440. doi: 10.1093/eurjpc/zwag440. Online ahead of print.NO ABSTRACTPMID:42663273 | DOI:10.1093/eurjpc/zwag440

K Kanyaw Kader

Workup and management of rhythm disorders in myocarditis and inflammatory cardiomyopathy: a clinical consensus statement of the European Heart Rhythm Association and the Heart Failure Association of the ESC, the ESC Working Group on Myocardial & Pericardial Diseases, the European Association of Preventive Cardiology of the ESC, the Heart Rhythm Society, the Asian Pacific Heart Rhythm Society, and the Latin American Heart Rhythm Society

Eur J Heart Fail. 2026 Aug 28:xuag271. doi: 10.1093/ejhf/xuag271. Online ahead of print.ABSTRACTMyocarditis is an important and frequently underrecognized cause of atrioventricular conduction disease and ventricular arrhythmias and may also be associated with atrial arrhythmias and sinus node dysfun

G Giovanni Peretto

Cancer in systemic sclerosis: clinical associations and prognostic impact from the EUSTAR registry

Arthritis Rheumatol. 2026 Aug 28. doi: 10.1002/art.70303. Online ahead of print.ABSTRACTBACKGROUND: Cancer represents a major cause of mortality in systemic sclerosis (SSc). Established risk factors are limited to specific subsets, particularly early diffuse anti-RNA polymerase III (POLR3)-positive

A Antonio Tonutti

Renal Single-Nucleus Transcriptomic of a New Model of Cardiovascular-Kidney-Metabolic (CKM) Syndrome in Aging Swine

Am J Physiol Renal Physiol. 2026 Aug 28. doi: 10.1152/ajprenal.00168.2026. Online ahead of print.ABSTRACTCKM syndrome entails pathophysiological interactions among the heart, the kidneys, and metabolic derangements. The specific cell populations implicated in renal injury have yet to be identified.

A Alfonso Eirin

Comparative Biomarker Efficacy of CETP Inhibitors: A Network Meta-Analysis

No abstractEur Heart J Cardiovasc Pharmacother. 2026 Aug 28:pvag067. doi: 10.1093/ehjcvp/pvag067. Online ahead of print.NO ABSTRACTPMID:42663147 | DOI:10.1093/ehjcvp/pvag067

M Maciej Banach